These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20864811)

  • 61. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
    Zage PE; Sirisaengtaksin N; Liu Y; Gireud M; Brown BS; Palla S; Richards KN; Hughes DP; Bean AJ
    Cancer; 2013 Feb; 119(4):915-23. PubMed ID: 22990745
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidence.
    Quatrale AE; Petriella D; Porcelli L; Tommasi S; Silvestris N; Colucci G; Angelo A; Azzariti A
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1973-85. PubMed ID: 21196277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.
    Maycotte P; Aryal S; Cummings CT; Thorburn J; Morgan MJ; Thorburn A
    Autophagy; 2012 Feb; 8(2):200-12. PubMed ID: 22252008
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EGFR inhibitors and autophagy in cancer treatment.
    Cui J; Hu YF; Feng XM; Tian T; Guo YH; Ma JW; Nan KJ; Zhang HY
    Tumour Biol; 2014 Dec; 35(12):11701-9. PubMed ID: 25293518
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrence.
    Grimaldi A; Balestrieri ML; D'Onofrio N; Di Domenico G; Nocera C; Lamberti M; Tonini G; Zoccoli A; Santini D; Caraglia M; Pantano F
    PLoS One; 2013; 8(11):e79658. PubMed ID: 24244540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p53 modulates acquired resistance to EGFR inhibitors and radiation.
    Huang S; Benavente S; Armstrong EA; Li C; Wheeler DL; Harari PM
    Cancer Res; 2011 Nov; 71(22):7071-9. PubMed ID: 22068033
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cetuximab induces eme1-mediated DNA repair: a novel mechanism for cetuximab resistance.
    Weinandy A; Piroth MD; Goswami A; Nolte K; Sellhaus B; Gerardo-Nava J; Eble M; Weinandy S; Cornelissen C; Clusmann H; Lüscher B; Weis J
    Neoplasia; 2014 Mar; 16(3):207-20, 220.e1-4. PubMed ID: 24731284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells.
    Fan J; Zeng X; Li Y; Wang S; Wang Z; Sun Y; Gao H; Zhang G; Feng M; Ju D
    PLoS One; 2013; 8(8):e72478. PubMed ID: 24015249
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Menin-mediated Repression of Glycolysis in Combination with Autophagy Protects Colon Cancer Against Small-molecule EGFR Inhibitors.
    Katona BW; Hojnacki T; Glynn RA; Paulosky KE; Szigety KM; Cao Y; Zhang X; Feng Z; He X; Ma J; Hua X
    Mol Cancer Ther; 2020 Nov; 19(11):2319-2329. PubMed ID: 32879052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EGFR signaling and autophagy dependence for growth, survival, and therapy resistance.
    Jutten B; Rouschop KM
    Cell Cycle; 2014; 13(1):42-51. PubMed ID: 24335351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Affinity Maturation of a Cyclic Peptide Handle for Therapeutic Antibodies Using Deep Mutational Scanning.
    van Rosmalen M; Janssen BM; Hendrikse NM; van der Linden AJ; Pieters PA; Wanders D; de Greef TF; Merkx M
    J Biol Chem; 2017 Jan; 292(4):1477-1489. PubMed ID: 27974464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Experimental tumor therapy].
    Baumann M; Zips D; Krause M
    Strahlenther Onkol; 2012 Nov; 188 Suppl 3():291-4. PubMed ID: 22895627
    [No Abstract]   [Full Text] [Related]  

  • 73. Autophagy and cancer therapy.
    Maycotte P; Thorburn A
    Cancer Biol Ther; 2011 Jan; 11(2):127-37. PubMed ID: 21178393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autophagy is a major metabolic regulator involved in cancer therapy resistance.
    Poillet-Perez L; Sarry JE; Joffre C
    Cell Rep; 2021 Aug; 36(7):109528. PubMed ID: 34407408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ex vivo programmed cell death and the prediction of response to chemotherapy.
    Nagourney RA
    Curr Treat Options Oncol; 2006 Mar; 7(2):103-10. PubMed ID: 16455021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Live imaging and single-cell analysis reveal differential dynamics of autophagy and apoptosis.
    Xu Y; Yuan J; Lipinski MM
    Autophagy; 2013 Sep; 9(9):1418-30. PubMed ID: 23748697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autophagy and cancer: Basic mechanisms and inhibitor development.
    Hama Y; Ogasawara Y; Noda NN
    Cancer Sci; 2023 Jul; 114(7):2699-2708. PubMed ID: 37010190
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Nano-Autophagy Inhibitor Triggering Reciprocal Feedback Control of Cholesterol Depletion for Solid Tumor Therapy.
    Zhang P; Shi Y; Xu Y; Liang Y; Huang C; Zhong D; Zhang Z; Yu Y; Zhang Z; Zhang J; Yu L; Zuo Y; Wang X; Niu H
    Adv Healthc Mater; 2023 Dec; 12(32):e2302020. PubMed ID: 37767984
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Autophagy-mediated nanomaterials for tumor therapy.
    Liao Z; Liu X; Fan D; Sun X; Zhang Z; Wu P
    Front Oncol; 2023; 13():1194524. PubMed ID: 38192627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer.
    Lee TG; Jeong EH; Kim SY; Kim HR; Kim CH
    Int J Cancer; 2015 Jun; 136(11):2717-29. PubMed ID: 25382705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.